Elevated Blood Sugar, Lower Gray Matter Volume Linked To Depression

Health & Lifestyle
425

Listen to article (english)

Translate to Spanish or other 102 languages!

Blood sugar may be a potential risk factor for depression and influence gray matter volume in the brain. Image for illustration purposes
Blood sugar may be a potential risk factor for depression and influence gray matter volume in the brain. Image for illustration purposes

Medical News Today

- Advertisement -
  • An estimated 5% of all adults around the world live with depression. 
  • Fluctuations in a person’s blood sugar levels are a known risk factor for depression. 
  • Researchers from Sun Yat-sen University believe reduced gray matter volume in the brain may mediate the link between blood sugar levels and depression risk. 

About 5% of the entire world’s adult populationTrusted Source lives with depression — a mental disorder leaving a person feeling very sad and hopeless to the point where they do not enjoy their normal activities. 

There are quite a few risk factorsTrusted Source for depression, one of which is fluctuations in glycemia or a person’s blood sugar levels.

Follow the link below to read the full story on Medical News Today:

- Advertisement -

https://www.medicalnewstoday.com/articles/elevated-blood-sugar-lower-gray-matter-volume-linked-to-depression

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Summer Break Weight Gain Is Real, With Latino Children Especially at Risk
Next article
FDA Approves First Nonprescription Daily Oral Contraceptive

More Articles

Sun Allergy Is Real: Signs, Causes, and How to Protect Your Skin

Is it possible to have a sun allergy? It may feel that way on a hot day, but for some people, that’s actually the case.

Beat the Summer Heat: Essential Hydration Tips

Summer heat has a way of sneaking up on you, making it easy to become dehydrated before you even realize you're thirsty.

STHS’ Transform Your Life Event Inspires Healthier Living Across the RGV

Whether you're making healthier food choices, becoming more active or focusing on your mental well-being, every positive change can help you live a longer, healthier and more fulfilling life.

No More Needles: FDA Approves First Daily Pill to Replace Injectable Cholesterol Drugs

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.
- Advertisement -